ZHANGZHOU , FUJIAN, CHINA, January 14, 2026 /EINPresswire.com/ -- Jiansheng Furniture (Fujian Jiansheng Furniture ...
ClariMed experts reveal how gender bias in medtech leads to safety risks for women and share strategies to create more ...
Introducing seven grassroots initiatives working to support local families and protect the city's architectural legacy ...
Findings challenge prevailing ignition–sustainment assumptions, reframing plasma instability as a systems-level ...
JIANGMEN, GUANGDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- International retailers, importers and lifestyle ...
An independent brand and web designer, IDEO CoLab Ventures design partner and co-founder of WE3, Charlota Blunarova's ...
Polyetheretherketone (PEEK) implants are widely used in cranioplasty, yet the clinical significance of implant surface design ...
Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...
The World Economic Forum, in conjunction with Accenture, sheds light on AI use cases across the globe that are operating at scale to deliver improved business outcomes ...
Medical watchdog group Do No Harm challenges study claiming racially diverse healthcare facilities improve Black patient ...
Central Banking’s regtech and suptech interviews are in‑depth exploration of the pioneering work at central banks and ...
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So it works quite well as a VEGFR inhibitor and it is de-risked in that sense.